In this episode, Peter Wunderli, Ph.D., discusses PPD's recent laboratory facility expansion, outlines challenges and critical factors in cell-based bio bioassay product development, talks about disease states suitable for this type of technology, and finally, takes a look into the future of cell-based assays.
Thought Leader: Peter Wunderli, Ph.D., Associate Director, Biopharmaceutical Services at PPD
